Biotin Anti-Human CD29 (integrin β1) Antibody
英诺赛图(InnoCyto)的 Biotin Anti-Human CD29 (integrin β1) Antibody(克隆 K20) 为鼠源 IgG2a 单克隆抗体,靶向 CD29(别名 Integrin β1 chain 等),Biotin 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥678 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 Biotin Anti-Human CD29 (integrin β1) Antibody(克隆 K20) 为鼠源 IgG2a 单克隆抗体,靶向 CD29(别名 Integrin β1 chain 等),Biotin 标记,适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥678 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
107207 | 25 μg | ¥678
107208 | 100 μg | ¥2,034
Product Details
Regulatory Status|RUO
Protein Concentration|0.2 mg/mL
Storage and Handling|The antibody solution should be stored between 2°C and 8°C
Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.25 µg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application. For detection, use a secondary reagent with this product.
See All Formats|Clone K20
Background Information
CD29, also known as integrin β1 (ITGB1), is a widely expressed cell surface adhesion molecule that plays a fundamental role in cell-cell and cell-extracellular matrix (ECM) interactions. CD29 is expressed on most cell types, including leukocytes, endothelial cells, epithelial cells, fibroblasts, and stem cells, and it partners with multiple integrin α subunits to form distinct functional receptors. Through these heterodimeric complexes, CD29 regulates cell adhesion, migration, survival, and signaling.
Structurally, CD29 is a type I transmembrane glycoprotein composed of a large extracellular domain, a single transmembrane helix, and a short cytoplasmic tail. The extracellular domain contains multiple conserved motifs, including an I-like domain and metal ion-dependent adhesion sites that are critical for ligand binding and conformational regulation. CD29 pairs with at least twelve different α integrin subunits (such as α1-α11 and αv) to form receptors including VLA-4 (α4β1), VLA-5 (α5β1), and VLA-6 (α6β1). The cytoplasmic tail of CD29 lacks intrinsic enzymatic activity but interacts with adaptor proteins such as talin and kindlin, linking integrins to the actin cytoskeleton and enabling bidirectional “inside-out” and “outside-in” signaling. The ligands of CD29-containing integrins are primarily ECM proteins, including fibronectin, collagen, laminin, and vitronectin, as well as certain cell surface counter-receptors such as VCAM-1. Ligand engagement regulates cell adhesion strength and initiates signaling pathways involving focal adhesion kinase (FAK), PI3K, and MAP kinases, influencing cell proliferation, differentiation, and survival.
CD29 plays important roles in disease. Dysregulated integrin β1 signaling contributes to cancer progression, invasion, and metastasis by promoting tumor cell adhesion, migration, and resistance to apoptosis. In immune-mediated diseases, CD29-containing integrins regulate leukocyte trafficking and tissue retention, influencing inflammatory responses and autoimmune pathology. CD29 expression has also been associated with fibrosis and abnormal wound healing due to its role in fibroblast activation and ECM remodeling.
Therapeutically, CD29 is relevant both as a target and as a biomarker. Integrin-directed therapies that block specific αβ1 complexes are used or under investigation to modulate immune cell trafficking and tumor-stromal interactions. In immunotherapy, high CD29 expression has been associated with cytotoxic and memory T cell subsets, making it a useful marker for selecting potent T cells in adoptive cell therapies. Additionally, targeting CD29-mediated adhesion pathways is being explored to overcome tumor immune evasion and therapy resistance, underscoring its broad relevance in translational medicine.
Data Sheets
Human peripheral blood lymphocytes stained either with biotinylated anti-human CD29 clone K20 (green histogram) or an isotype control (gray histogram), followed by SA-PE.
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). Biotin Anti-Human CD29 (integrin β1) Antibody(107207)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/biotin-anti-human-cd29-integrin-1-antibody.html.
TeleVM. (2026, November 12). Biotin Anti-Human CD29 (integrin β1) Antibody(107207). 产品目录. https://www.suprotek.cn/products/item/biotin-anti-human-cd29-integrin-1-antibody.html
@misc{biocsp_item_biotin_anti_human_cd29_integrin_1_antibody,
title = {Biotin Anti-Human CD29 (integrin β1) Antibody(107207)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/biotin-anti-human-cd29-integrin-1-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源